Clinical Trial Update: Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating how colchicine therapy affects proteomic and inflammatory omics in patients with coronary heart disease, with recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Coronary Heart Disease (CHD) | Phase 4 | Status: NOT_YET_RECRUITING